Investing.com - Qiagen reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Qiagen announced earnings per share of $0.648 on revenue of $509.63M. Analysts polled by Investing.com anticipated EPS of $0.5275 on revenue of $462.62M.
Qiagen shares are down 12% from the beginning of the year and are trading at $43.000 , down-from-52-week-high.They are under-performing the DAX which is down 4.04% from the start of the year.
Qiagen follows other major Healthcare sector earnings this month
Qiagen's report follows an earnings beat by Siemens Healthineers on Thursday, February 3, 2022, who reported EPS of $0.55 on revenue of $5.07B, compared to forecasts EPS of $0.505 on revenue of $4.9B.
Sartorius AG VZO had matched expectations on Thursday, January 27, 2022 with fourth quarter EPS of $2.14 on revenue of $922.3M (NYSE:MMM), compared to forecast for EPS of $2.14 on revenue of $922.38M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar